UBS Group’s Axonex AI Group Limited Class A Ordinary Shares AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32 Sell
14
-1,545
-99% -$4.64K ﹤0.01% 10228
2026
Q1
$4.21K Buy
1,559
+1,156
+287% +$3.65K ﹤0.01% 8966
2025
Q4
$1.21K Sell
403
-5,725
-93% -$166K ﹤0.01% 9659
2025
Q3
$481K Buy
6,128
+6,017
+5,421% +$484K ﹤0.01% 6119
2025
Q2
$7.36K Buy
+111
New +$5.65K ﹤0.01% 9024

Other funds holding AXNX

UBS Group's AXNX Position: Q2 2026 in Review

UBS Group reduced its Axonex AI Group Limited Class A Ordinary Shares (AXNX) stake by 99% in Q2 2026, selling an estimated $4.64K and leaving 14 shares worth $32. The position accounts for ﹤0.01% of the portfolio, ranked #10228.

UBS Group first reported a position in AXNX in Q2 2025 and has held it in 5 quarters since. The position peaked at $481K in Q3 2025. 7 funds tracked by Wall St. Rank hold AXNX as of Q2 2026.

  • UBS Group held 14 shares of Axonex AI Group Limited Class A Ordinary Shares worth $32 as of Q2 2026.
  • UBS Group sold 1,545 Axonex AI Group Limited Class A Ordinary Shares shares in Q2 2026, an estimated $4.64K.
  • Axonex AI Group Limited Class A Ordinary Shares made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #10228 holding.
  • UBS Group first reported a position in Axonex AI Group Limited Class A Ordinary Shares in Q2 2025 and has held it in 5 quarters since.
  • UBS Group's Axonex AI Group Limited Class A Ordinary Shares position peaked at $481K in Q3 2025.
  • 7 funds tracked by Wall St. Rank held Axonex AI Group Limited Class A Ordinary Shares as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.